scholarly article | Q13442814 |
P50 | author | Marta Bosch | Q46862255 |
Priam Villalonga | Q58762501 | ||
Richard Marais | Q30118915 | ||
Joan Gil | Q39031928 | ||
Neus Agell | Q42808828 | ||
P2093 | author name string | C J Marshall | |
O Bachs | |||
N Rocamora | |||
A Chiloeches | |||
C López-Alcalá | |||
P2860 | cites work | Regulation of mitogen-activated protein kinases by a calcium/calmodulin-dependent protein kinase cascade | Q24312887 |
Cloning and characterization of Ras-GRF2, a novel guanine nucleotide exchange factor for Ras | Q24647108 | ||
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation | Q28131755 | ||
A scaffold protein in the c-Jun NH2-terminal kinase signaling pathways suppresses the extracellular signal-regulated kinase signaling pathways | Q28142006 | ||
Proteins regulating Ras and its relatives | Q28257295 | ||
New nuclear functions for calmodulin | Q28271858 | ||
Calmodulin is essential for cyclin-dependent kinase 4 (Cdk4) activity and nuclear accumulation of cyclin D1-Cdk4 during G1 | Q28290353 | ||
Calmodulin inhibitor W13 induces sustained activation of ERK2 and expression of p21(cip1). | Q42827172 | ||
The human epidermal growth factor receptor contains a juxtamembrane calmodulin-binding site. | Q42832751 | ||
Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation. | Q42991716 | ||
Coordinate, biphasic activation of p44 mitogen-activated protein kinase and S6 kinase by growth factors in hamster fibroblasts. Evidence for thrombin-induced signals different from phosphoinositide turnover and adenylylcyclase inhibition | Q67852243 | ||
Calmodulin inhibits the epidermal growth factor receptor tyrosine kinase | Q67854307 | ||
Calmodulin and the cell cycle: involvement in regulation of cell-cycle progression | Q70307152 | ||
Calmodulin | Q71480256 | ||
Calcium/calmodulin-dependent protein kinase IIalpha mediates activation of mitogen-activated protein kinase and cytosolic phospholipase A2 in norepinephrine-induced arachidonic acid release in rabbit aortic smooth muscle cells | Q71825158 | ||
The dual specificity mitogen-activated protein kinase phosphatase-1 and -2 are induced by the p42/p44MAPK cascade | Q71973754 | ||
Overexpression of the myristoylated alanine-rich C-kinase substrate in Rat1 cells increases sensitivity to calmodulin antagonists | Q72796962 | ||
Ras isoforms vary in their ability to activate Raf-1 and phosphoinositide 3-kinase | Q77195536 | ||
ras oncogenes in human cancer: a review | Q29547769 | ||
ras genes | Q29547799 | ||
MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo | Q29615244 | ||
Mitogen-activated protein kinase pathways | Q29618431 | ||
Phosphatidylinositol-3-OH kinase as a direct target of Ras | Q29620177 | ||
Ras caught in another affair: the exchange factors for Ral. | Q33540078 | ||
Epidermal growth factor receptors: critical mediators of multiple receptor pathways | Q33597368 | ||
Ras proteins: recent advances and new functions. | Q33771484 | ||
How do small GTPase signal transduction pathways regulate cell cycle entry? | Q33796334 | ||
Growth factor activation of MAP kinase requires cell adhesion. | Q33887464 | ||
Signal transduction from multiple Ras effectors | Q34415796 | ||
The murine N-ras gene is not essential for growth and development | Q34650223 | ||
Ras signalling and apoptosis | Q34746668 | ||
Regulation of the calmodulin-stimulated protein phosphatase, calcineurin | Q34747325 | ||
K-ras is an essential gene in the mouse with partial functional overlap with N-ras | Q35192456 | ||
Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway | Q35952074 | ||
Growth factor-induced p42/p44 MAPK nuclear translocation and retention requires both MAPK activation and neosynthesis of nuclear anchoring proteins | Q36288233 | ||
Regulation of p21ras by GTPase activating proteins and guanine nucleotide exchange proteins | Q36333750 | ||
Spectrin and related molecules | Q36427874 | ||
Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1. | Q36572588 | ||
Nerve growth factor activation of the extracellular signal-regulated kinase pathway is modulated by Ca(2+) and calmodulin. | Q39584779 | ||
Phosphorylation of rat liver heterogeneous nuclear ribonucleoproteins A2 and C can be modulated by calmodulin | Q40021377 | ||
High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1. | Q40023426 | ||
Calmodulin and calmodulin-binding proteins in the nucleus | Q40569007 | ||
Opposing effects of Ras on p53: transcriptional activation of mdm2 and induction of p19ARF. | Q40845331 | ||
Role of basal calcium in the EGF activation of MAP kinases | Q40884737 | ||
Regulation of the cell cycle by calcium and calmodulin | Q40906159 | ||
The multifunctional Ca2+/calmodulin-dependent protein kinases | Q40914645 | ||
Dominant-negative caveolin inhibits H-Ras function by disrupting cholesterol-rich plasma membrane domains | Q40918552 | ||
Calmodulin binds to p21(Cip1) and is involved in the regulation of its nuclear localization | Q40934326 | ||
Calcium influx activates extracellular-regulated kinase/mitogen-activated protein kinase pathway through a calmodulin-sensitive mechanism in PC12 cells | Q40985633 | ||
Calmodulin modulates mitogen-activated protein kinase activation in response to membrane depolarization in PC12 cells | Q41039873 | ||
Ras effectors | Q41099716 | ||
Regulation of mitogen-activated protein kinase phosphatase-1 expression by extracellular signal-related kinase-dependent and Ca2+-dependent signal pathways in Rat-1 cells | Q41109924 | ||
The hsp90-binding antibiotic geldanamycin decreases Raf levels and epidermal growth factor signaling without disrupting formation of signaling complexes or reducing the specific enzymatic activity of Raf kinase | Q41127933 | ||
Minimal Ras-binding domain of Raf1 can be used as an activation-specific probe for Ras. | Q41128325 | ||
Calcium activation of Ras mediated by neuronal exchange factor Ras-GRF. | Q41312875 | ||
Increasing complexity of Ras signal transduction: involvement of Rho family proteins | Q41617077 | ||
Calmodulin regulates DNA polymerase alpha activity during proliferative activation of NRK cells | Q41623918 | ||
Mechanism of activation and function of protein kinase B. | Q41732739 | ||
Signal transduction through MAP kinase cascades | Q41750250 | ||
P433 | issue | 21 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cell biology | Q7141 |
P304 | page(s) | 7345-54 | |
P577 | publication date | 2001-11-01 | |
P1433 | published in | Molecular and Cellular Biology | Q3319478 |
P1476 | title | Calmodulin binds to K-Ras, but not to H- or N-Ras, and modulates its downstream signaling | |
P478 | volume | 21 |
Q36278636 | A New View of Ras Isoforms in Cancers |
Q54977087 | A Putative Mechanism of Age-Related Synaptic Dysfunction Based on the Impact of IGF-1 Receptor Signaling on Synaptic CaMKIIα Phosphorylation. |
Q37234348 | A clathrin-dependent pathway leads to KRas signaling on late endosomes en route to lysosomes. |
Q49898832 | A head-to-tail view of L-selectin and its impact on neutrophil behaviour |
Q50037291 | A high pressure study of calmodulin-ligand interactions using small-angle X-ray and elastic incoherent neutron scattering |
Q93018032 | A model for RAS mutation patterns in cancers: finding the sweet spot |
Q30571548 | A role for sorting nexin 27 in AMPA receptor trafficking. |
Q24601002 | Activation of H-Ras in the endoplasmic reticulum by the RasGRF family guanine nucleotide exchange factors |
Q44805261 | Application of reductive ¹³C-methylation of lysines to enhance the sensitivity of conventional NMR methods. |
Q91889015 | Autoinhibition in Ras effectors Raf, PI3Kα, and RASSF5: a comprehensive review underscoring the challenges in pharmacological intervention |
Q42811646 | Binding of calmodulin to the carboxy-terminal region of p21 induces nuclear accumulation via inhibition of protein kinase C-mediated phosphorylation of Ser153. |
Q33959398 | Both the C-terminal polylysine region and the farnesylation of K-RasB are important for its specific interaction with calmodulin |
Q45897176 | CBP501 inhibits EGF-dependent cell migration, invasion and epithelial-to-mesenchymal transition of non-small cell lung cancer cells by blocking KRas to calmodulin binding |
Q40650772 | Ca2+/calmodulin binds and dissociates K-RasB from membrane |
Q41807072 | CaM interaction and Ser181 phosphorylation as new K-Ras signaling modulators. |
Q42315515 | Calcium-dependent binding of Myc to calmodulin. |
Q27865262 | Calcium/calmodulin-dependent protein kinase II (CaMKII) phosphorylates Raf-1 at serine 338 and mediates Ras-stimulated Raf-1 activation. |
Q40637860 | Calcium/calmodulin-dependent protein kinase II binds to Raf-1 and modulates integrin-stimulated ERK activation |
Q38809850 | Calmodulin and PI3K Signaling in KRAS Cancers |
Q42528773 | Calmodulin mediates brain-derived neurotrophic factor cell survival signaling upstream of Akt kinase in embryonic neocortical neurons |
Q42811805 | Calmodulin prevents activation of Ras by PKC in 3T3 fibroblasts |
Q33899188 | Calmodulin regulates intracellular trafficking of epidermal growth factor receptor and the MAPK signaling pathway. |
Q40537107 | Calmodulin-mediated activation of Akt regulates survival of c-Myc-overexpressing mouse mammary carcinoma cells |
Q37642081 | Calmodulin-mediated regulation of the epidermal growth factor receptor. |
Q91891960 | Capturing the primordial Kras mutation initiating urethane carcinogenesis |
Q38981868 | Cell activation-induced phosphoinositide 3-kinase alpha/beta dimerization regulates PTEN activity |
Q34384654 | Characterization and functional analysis of the calmodulin-binding domain of Rac1 GTPase |
Q49164077 | Comparative Nucleotide-Dependent Interactome Analysis Reveals Shared and Differential Properties of KRas4a and KRas4b |
Q35163908 | Control of Ras cycling by Ca2+. |
Q44193402 | Control of oxidative stress resistance by IP3 kinase in Drosophila melanogaster. |
Q33201276 | Development of gene therapy to target pancreatic cancer |
Q92296226 | Endogenous IQGAP1 and IQGAP3 do not functionally interact with Ras |
Q38721757 | Flexible-body motions of calmodulin and the farnesylated hypervariable region yield a high-affinity interaction enabling K-Ras4B membrane extraction. |
Q90357653 | From basic researches to new achievements in therapeutic strategies of KRAS-driven cancers |
Q42784309 | Functional specificity of ras isoforms: so similar but so different |
Q40243821 | Growth factor-dependent AKT activation and cell migration requires the function of c-K(B)-Ras versus other cellular ras isoforms |
Q36276948 | Growth inhibition of non-small-cell lung carcinoma by BN/GRP antagonist is linked with suppression of K-Ras, COX-2, and pAkt |
Q37113976 | How to Target Activated Ras Proteins: Direct Inhibition vs. Induced Mislocalization |
Q24323920 | IQGAP1 integrates Ca2+/calmodulin and B-Raf signaling |
Q42818368 | Identification of essential interacting elements in K-Ras/calmodulin binding and its role in K-Ras localization |
Q42808601 | Identification of the nuclear localization signal of p21(cip1) and consequences of its mutation on cell proliferation. |
Q37136831 | In Vitro and in Vivo Characterization of Molecular Interactions between Calmodulin, Ezrin/Radixin/Moesin, and L-selectin |
Q54123759 | Interaction of Calmodulin with the cSH2 Domain of the p85 Regulatory Subunit. |
Q58759673 | Interrogating the protein interactomes of RAS isoforms identifies PIP5K1A as a KRAS-specific vulnerability |
Q39361391 | Intrinsic protein disorder in oncogenic KRAS signaling |
Q24298001 | K-Ras4B phosphorylation at Ser181 is inhibited by calmodulin and modulates K-Ras activity and function |
Q92204540 | KRAS Prenylation Is Required for Bivalent Binding with Calmodulin in a Nucleotide-Independent Manner |
Q27007866 | KRAS as a Therapeutic Target |
Q100156058 | KRAS4B is phosphorylated on serine 181 |
Q30412447 | Mechanisms of sensorineural cell damage, death and survival in the cochlea. |
Q58098402 | Modeling and subtleties of K-Ras and Calmodulin interaction |
Q38641385 | Modeling of RAS complexes supports roles in cancer for less studied partners |
Q34646533 | Modulation of the Ras/Raf/MEK/ERK pathway by Ca(2+), and calmodulin |
Q42364777 | Multiple Cellular Proteins Modulate the Dynamics of K-ras Association with the Plasma Membrane |
Q50060605 | New weapons to penetrate the armor: Novel reagents and assays developed at the NCI RAS Initiative to enable discovery of RAS therapeutics |
Q98771864 | Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical Implications |
Q37610817 | Non-redundancy within the RAS oncogene family: insights into mutational disparities in cancer |
Q36528910 | Nonconventional trafficking of Ras associated with Ras signal organization |
Q42445553 | Oncogenic HRAS mutations cause prolonged PI3K signaling in response to epidermal growth factor in fibroblasts of patients with Costello syndrome |
Q47256433 | Oncogenic Ras Isoforms Signaling Specificity at the Membrane |
Q47424576 | Phosphorylated Calmodulin Promotes PI3K Activation by Binding to the SH2 Domains |
Q30051177 | Phosphorylation of calmodulin |
Q36765168 | Plasma membrane regulates Ras signaling networks |
Q34713721 | Plasma membrane targeting is essential for Rem-mediated Ca2+ channel inhibition |
Q38614956 | Principles of K-Ras effector organization and the role of oncogenic K-Ras in cancer initiation through G1 cell cycle deregulation |
Q51367428 | Probing conformational and functional substates of calmodulin by high pressure FTIR spectroscopy: influence of Ca2+ binding and the hypervariable region of K-Ras4B. |
Q90595812 | Quantitative biophysical analysis defines key components modulating recruitment of the GTPase KRAS to the plasma membrane |
Q39407402 | RAS Proteins and Their Regulators in Human Disease |
Q42806256 | Rac1 and calmodulin interactions modulate dynamics of ARF6-dependent endocytosis. |
Q33721174 | Ras and calcium signaling pathways converge at Raf1 via the Shoc2 scaffold protein |
Q40052806 | Ras isoform abundance and signalling in human cancer cell lines. |
Q28769530 | Ras plasma membrane signalling platforms |
Q35120159 | Ras proteins: different signals from different locations |
Q36880352 | Ras proteins: paradigms for compartmentalised and isoform-specific signalling. |
Q33351823 | Ras, an actor on many stages: posttranslational modifications, localization, and site-specified events. |
Q35818835 | Ras-GTP dimers activate the Mitogen-Activated Protein Kinase (MAPK) pathway |
Q58767599 | Recent Findings on AMPA Receptor Recycling |
Q39606227 | Regulation of K-Ras4B Membrane Binding by Calmodulin |
Q34685547 | Rem GTPase interacts with the proximal CaV1.2 C-terminus and modulates calcium-dependent channel inactivation |
Q34166819 | Replacement of K-Ras with H-Ras supports normal embryonic development despite inducing cardiovascular pathology in adult mice |
Q36320940 | Reversible intracellular translocation of KRas but not HRas in hippocampal neurons regulated by Ca2+/calmodulin. |
Q44026023 | Role of calmodulin in the modulation of the MAPK signalling pathway and the transactivation of epidermal growth factor receptor mediated by PKC. |
Q100156061 | S-Farn-Me KRAS4B binds calmodulin |
Q34989689 | Shuttling and translocation of heterotrimeric G proteins and Ras. |
Q59356059 | Small GTPase RAS in multiple sclerosis - exploring the role of RAS GTPase in the etiology of multiple sclerosis |
Q28572715 | Subtoxic N-methyl-D-aspartate delayed neuronal death in ischemic brain injury through TrkB receptor- and calmodulin-mediated PI-3K/Akt pathway activation |
Q28571239 | Suprachiasmatic nucleus circadian oscillatory protein, a novel binding partner of K-Ras in the membrane rafts, negatively regulates MAPK pathway |
Q27021883 | The Key Role of Calmodulin in KRAS-Driven Adenocarcinomas |
Q34765346 | The Ras inhibitor farnesylthiosalicylic acid (Salirasib) disrupts the spatiotemporal localization of active Ras: a potential treatment for cancer |
Q36669604 | The disordered hypervariable region and the folded catalytic domain of oncogenic K-Ras4B partner in phospholipid binding |
Q27334550 | The distinct conformational dynamics of K-Ras and H-Ras A59G |
Q37312050 | The hypervariable region of K-Ras4B is responsible for its specific interactions with calmodulin |
Q60937346 | The multifunctional role of phospho-calmodulin in pathophysiological processes |
Q54518814 | The structural plasticity of the C terminus of p21Cip1 is a determinant for target protein recognition. |
Search more.